PhEur Reference Standards - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PhEur Reference Standards

Most European Pharmacopoeia monographs refer to the use of reference standards (samples of thoroughly characterised substances, intended for use in the tests and assays described in the European Pharmacopoeia). The availability of these standards is essential for the application of the European Pharmacopoeia. The collection of reference standards used for the implementation of the European Pharmacopoeia now consists of more than 2500 substances or mixtures derived from chemical, biological or herbal origin. Their use extends far beyond the European continent. The online database contains over 2500 reference standards and is updated daily. Search by catalogue code, name, monograph or CAS number to find the standard you need. The EDQM also provides Batch Validity Statements, Safety Data Sheets and leaflets to download.

Download the Catalogue today at:
http://crs.edqm.eu/db/4DCGI/web_catalog_CRS

Search the PhEur Reference Standards Database:
http://crs.edqm.eu/

EDQM, Council of Europe
Website: www.edqm.eu & www.edqm.eu/store
E-mail: orders@edqm.eu

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here